Matthias Puls

Matthias Puls drives digital transformation in healthcare at the intersection of MedTech and Pharma. He is Managing Director of Puls & Partners Advisory, where he focuses on innovative business models, go-to-market strategies, and business development for digital health solutions – from early concept and clinical validation to market launch and commercialization. Currently, Matthias serves as CEO of Ceregate GmbH, advancing the treatment of neurological disorders with its minimally invasive Computer-Brain Interface (CBI) technology.

Previously, he directed the global Digital Therapeutics (DTx) and Digital Health Solutions portfolio at Gerresheimer AG, where he was responsible for shaping the company’s digital health strategy and building high-performing teams. Earlier in his career, Matthias held senior roles at Biotronik and was Managing Director of the Berlin-based digital health start-up Kenkou (cardiovascular biomarkers). He began in international management consulting, most recently at Baringa Partners LLP in Düsseldorf and London, with a focus on strategy, organizational development, and process transformation. In addition, he lectures on digital business models in healthcare at leading European universities.

Puls earned his MBA degree in Berlin and completed his degree in economics (specializing in entrepreneurship) at the Johannes Kepler University Linz, the Copenhagen Business School and Trinity College Dublin.